Amy Shurtleff, Ph.D., works in a biosafety level 4 laboratory at U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). Shurtleff is part of a team that evaluated the protective efficacy of Merck's EBOV vaccine, V920. (Image courtesy of U.S. Army Medical Research Institute of Infectious Diseases)
Defense Threat Reduction Agency's Chemical and Biological Technologies DepartmentFort Belvoir, Virginia, United StatesMar 16, 2018